State Street’s Athira Pharma ATHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.4K Hold
107,381
﹤0.01% 4156
2025
Q1
$30.6K Hold
107,381
﹤0.01% 4157
2024
Q4
$63K Sell
107,381
-400
-0.4% -$235 ﹤0.01% 4074
2024
Q3
$48.1K Hold
107,781
﹤0.01% 4111
2024
Q2
$286K Hold
107,781
﹤0.01% 3719
2024
Q1
$295K Hold
107,781
﹤0.01% 3780
2023
Q4
$262K Hold
107,781
﹤0.01% 3831
2023
Q3
$218K Sell
107,781
-10,700
-9% -$21.6K ﹤0.01% 3915
2023
Q2
$350K Sell
118,481
-664,129
-85% -$1.96M ﹤0.01% 3805
2023
Q1
$1.96M Buy
782,610
+3,597
+0.5% +$8.99K ﹤0.01% 3350
2022
Q4
$2.47M Sell
779,013
-3,141
-0.4% -$9.96K ﹤0.01% 3311
2022
Q3
$2.32M Sell
782,154
-128,221
-14% -$381K ﹤0.01% 3374
2022
Q2
$2.78M Buy
910,375
+82,801
+10% +$253K ﹤0.01% 3369
2022
Q1
$11.2M Buy
827,574
+232,280
+39% +$3.14M ﹤0.01% 2764
2021
Q4
$7.76M Buy
595,294
+110,041
+23% +$1.43M ﹤0.01% 3038
2021
Q3
$4.55M Buy
485,253
+51,935
+12% +$487K ﹤0.01% 3287
2021
Q2
$4.44M Buy
433,318
+220,967
+104% +$2.26M ﹤0.01% 3305
2021
Q1
$3.91M Buy
212,351
+15,496
+8% +$285K ﹤0.01% 3158
2020
Q4
$6.74M Buy
+196,855
New +$6.74M ﹤0.01% 2817